 TRIAL OF ALLOGENEIC STEM CELL TRANSPLANTS FROM HLA COMPATIBLE, RELATED AND UNRELATED DONORS AFTER A MYELOABLATIVE PREPARATIVE REGIMEN WITH HYPERFRACTIONATED TBI, THIOTEPA AND FLUDARABINE FOR ADULT PATIENTS WITH LYMPHOHEMATOPOIETIC DISORDERS: 